簡要描述:膜相關(guān)環(huán)指蛋白2抗體免 疫 原;KLH conjugated synthetic peptide derived from human MARCH2: 151-246/246
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
膜相關(guān)環(huán)指蛋白2抗體
產(chǎn)品名稱 | 英文名稱 | 貨號(hào) |
膜相關(guān)環(huán)指蛋白2抗體 | 2-MAR | GOY-01K0566 |
商品屬性:
英文名稱: 2-MAR
中文名:膜相關(guān)環(huán)指蛋白2抗體
別 名;E3 ubiquitin
protein ligase MARCH2; E3 ubiquitin-protein ligase MARCH2; EC 6.3.2.- antibody
HSPC240; MARCH II; MARCH-II; march2; MARH2_HUMAN antibody Membrane associated
RING CH protein II; Membrane associated ring finger (C3HC4) 2; Membrane
associated RING finger protein 2; Membrane-associated RING finger protein 2;
Membrane-associated RING-CH protein II; RING finger protein 172; RNF172.
研究領(lǐng)域;細(xì)胞生物 通道蛋白 鋅指蛋白
抗體來源;Rabbit
克隆類型;Polyclonal
交叉反應(yīng);(predicted:
Human, Mouse, Rat, )
產(chǎn)品應(yīng)用;WB=1:500-2000
ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;27kDa
細(xì)胞定位;細(xì)胞漿 細(xì)胞膜
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from human MARCH2: 151-246/246
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項(xiàng);This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
Ubiquitination is an important mechanism through
which three classes of enzymes act in concert to target short-lived or
abnormal proteins for destruction. The three classes of enzymes involved in
ubiquitination are the ubiquitin-activating enzymes (E1s), the
ubiquitin-conjugating enzymes (E2s) and the ubiquitin-protein ligases (E3s).
MARCH2 (membrane-associated ring finger (C3HC4) 2), also known as RNF172 or
HSPC240, is a 246 amino acid multi-pass membrane protein that localizes to
the endoplasmic reticulum and contains one RING-CH-type zinc finger.
Expressed in a variety of tissues, MARCH2 functions as an E3
ubiquitin-protein ligase that is thought to mediate the ubiquitination and
subsequent degradation of CD71 and B7-2 and may be involved in endosomal
protein trafficking. E3 ubiquitin-protein ligase that may mediate
ubiquitination of TFRC and CD86, and promote their subsequent endocytosis and
sorting to lysosomes via multivesicular bodies. E3 ubiquitin ligases accept
ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester
and then directly transfer the ubiquitin to targeted substrates. May be
involved in endosomal trafficking through interaction with STX6. |
多克隆抗體制備:
我公司合成抗原,保證陽性血清和抗體ELISA效價(jià)達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測結(jié)果是陽性。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項(xiàng)目實(shí)際需求情況靈活選擇進(jìn)行,我公司將為您的項(xiàng)目提供專業(yè)的建議。在制備過程中,與客戶互動(dòng)驗(yàn)證,確保最終制備的抗體ELISA陽性血清檢測達(dá)到合同要求的同時(shí),也能滿足客戶抗體最終應(yīng)用驗(yàn)證需求。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
重組抗體表達(dá)服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無法做到的。我公司已搭建好的抗體測序、重組抗體表達(dá)等先進(jìn)平臺(tái),能為客戶提供各種類型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。
單項(xiàng)免疫學(xué)及檢測服務(wù):
我公司也為客戶提供單項(xiàng)免疫學(xué)和檢測服務(wù),如動(dòng)物免疫、動(dòng)物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測服務(wù)。
抗體定制服務(wù):
已注冊(cè)商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對(duì)有特定應(yīng)用要求和各種模型測試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關(guān)注我們的微信了解更多信息
電話
微信掃一掃